Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes? - report from ASH2024

from Medical Digest & Congress Report · host Medical Congress News

Cho Han Chiang, MD, MMSc presented an analysis at the 2024 ASH Annual Meeting, that shows GLP-1 receptor agonists led to a significant reduction in the risk for VTE among individuals with type 2 diabetes, compared with DPP-4 inhibitors, a recent indicated. Video: https://medicaldigest.org/scientific-contents/interview:do-glp-1s-lower-vte-risk-people-type-2-diabetes

Episode metadata supplied by the publisher feed · Published Dec 22, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes? - report from ASH2024

0:00 2:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 2 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 22, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!